NPI: 1275620841 · EUCLID, OH 44117 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/06/2006
Authorized official NEMECEK, GAYLE controls 18+ related entities in our dataset. Read more
| Authorized Official | NEMECEK, GAYLE (COO) |
| NPI Enumeration Date | 10/06/2006 |
Other providers sharing the same authorized official: NEMECEK, GAYLE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,462 | $58K |
| 2019 | 6,130 | $158K |
| 2020 | 7,248 | $136K |
| 2021 | 5,634 | $106K |
| 2022 | 4,498 | $110K |
| 2023 | 3,783 | $106K |
| 2024 | 4,897 | $134K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 10,927 | 905 | $749K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 826 | 441 | $32K |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 163 | 59 | $15K |
| Q5105 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units | 2,545 | 278 | $6K |
| 83970 | 876 | 724 | $2K | |
| J2501 | Injection, paricalcitol, 1 mcg | 3,122 | 296 | $1K |
| J1756 | Injection, iron sucrose, 1 mg | 426 | 120 | $511.34 |
| 82728 | 896 | 739 | $398.97 | |
| 84466 | 903 | 747 | $381.72 | |
| 82310 | 917 | 734 | $328.23 | |
| 82565 | 919 | 746 | $322.03 | |
| 82374 | 897 | 734 | $314.91 | |
| 82040 | 899 | 734 | $312.59 | |
| 82435 | 897 | 734 | $306.84 | |
| 84520 | 1,964 | 768 | $221.04 | |
| 83540 | 903 | 747 | $196.82 | |
| 84075 | 892 | 734 | $144.95 | |
| 84100 | 930 | 762 | $143.37 | |
| 84132 | 897 | 734 | $134.74 | |
| 85045 | 909 | 747 | $121.42 | |
| 84295 | 601 | 490 | $116.68 | |
| 87340 | 636 | 513 | $106.20 | |
| 84155 | 596 | 490 | $88.81 | |
| 86706 | 111 | 95 | $24.90 |